August 25, 2026 - 8-K: Current report

Datavault AI Inc. (DVLT) received a 180-day extension from Nasdaq to comply with the $1 minimum bid price requirement, now due by February 22, 2027. The company previously failed to meet this requirement by the initial deadline of August 24, 2026. DVLT's stock continues to trade on the Nasdaq Capital Market under the symbol 'DVLT' during this period.

Original reporting
Published Aug 25, 2026, 11:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 3:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
August 25, 2026 - 8-K: Current report — source image
Decision brief

The 30-second read

$DVLTNeutralMed
01

Why it matters

The extension keeps the stock listed but underscores compliance risk, likely prompting heightened monitoring by traders.

02

Market read

Primary relevance to DVLT shareholders and micro‑cap traders; limited broader market effect.

03

What to watch

Potential for a reverse stock split or strategic partnership that could quickly lift the share price above $1.

Relevance 7/10Novelty 7/10Timing: August 25 2026 (today)

Background

Datavault AI Inc. (DVLT) failed to meet Nasdaq's $1 minimum bid price for 30 days and was granted a 180‑day extension to regain compliance.

Company-level read

Ticker impact

$DVLTNeutralHigh confidence
Context

Datavault AI Inc. received a Nasdaq extension to regain $1.00 bid price compliance, adding 180 days to avoid delisting.

Expected impact

downward pressure if bid stays below $1, upside if price recovers above threshold.

Evidence & confidence

Extension indicates continued listing but highlights ongoing compliance risk, influencing trader sentiment.

Market effects

Other low-priced Nasdaq Capital Market stocks may face similar compliance scrutiny.

Minimal impact on broader US market; localized to micro‑cap segment.

Low; primarily affects US-listed micro‑cap investors.

Counterpoint

If the company successfully executes a reverse split, the extension could be a catalyst for a rebound.

Key entities

  • Datavault AI Inc.

    Issuer of DVLT, seeking to regain Nasdaq compliance.

  • Nasdaq

    Provided the compliance extension.

Related articles

$MEDSMedAI 8/10

A proposed deal could combine health-goal tracking with prescription delivery by drone

DataMEDS AI (NASDAQ:MEDS) announced a non-binding LOI with Datavault AI (NASDAQ:DVLT), others, to acquire QOLPOM IP and expand its healthcare ecosystem. The deal aims to integrate health tracking, prescription delivery, and AI/blockchain tech, with a Q4 2026 target close. FDA guidance supports the optimization of DataMEDS' Health Lives Here app. The transaction is subject to due diligence and regulatory approvals.

$DVLTMed

Datavault AI Lands $100 Million Order for Tokenization Services

Datavault AI Inc. (DVLT) received a $100M order for its $QEST tokenization services, launching three commercial platforms. The company projects $200M in 2026 revenue, with tokenization contributing in 2026-2027. Platforms include Information Data Exchange, NILvault, and American Political Exchange, focusing on data and real-world asset tokenization.